High-dose intravenous vitamin C may enhance chemotherapy effectiveness, particularly in pancreatic cancer, by acting as a prooxidant. Despite promising results, further phase 3 trials are needed to confirm its potential benefits in cancer treatment.
High-dose intravenous vitamin C may enhance chemotherapy effectiveness, particularly in pancreatic cancer, by acting as a prooxidant. Despite promising results, further phase 3 trials are needed to confirm its potential benefits in cancer treatment.